Furthermore, considering all soluble factors, linear discriminant analysis (LDA) revealed that BC patient monocyte subgroups (refractory and sensitive to GM‐CSF) could be separated into 2 clusters by a combination of twelve cytokines (Supplementary figure 3). This evidence concerns the gene CSF2 and breast cancer.